(-0.05%) 5 466.71 points
(0.08%) 39 143 points
(0.23%) 17 758 points
(0.80%) $81.48
(-4.68%) $2.63
(-0.75%) $2 313.40
(0.18%) $28.92
(3.60%) $1 021.90
(0.26%) $0.936
(0.61%) $10.67
(0.39%) $0.791
(-0.29%) $87.24
0.00% $ 381.02
Live Chart Being Loaded With Signals
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients...
Stats | |
---|---|
Tagesvolumen | 15.70M |
Durchschnittsvolumen | 1.70M |
Marktkapitalisierung | 17.18B |
EPS | $2.34 ( Q2 | 2022-11-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
65.36 (Sector) 42.63 (Industry) 43.86 |
ATR14 | $4.67 (1.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-22 | Sutter Martin P | Sell | 123 370 | Common Stock, $0.01 par value |
2022-12-22 | Puhy Dorothy E | Sell | 11 335 | Common Stock, $0.01 par value |
2022-12-22 | Trapp Todd A | Buy | 26 023 | Performance Stock Units |
2022-12-22 | Trapp Todd A | Sell | 26 023 | Performance Stock Units |
2022-12-22 | Plano Matthew T. | Buy | 12 490 | Performance Stock Units |
INSIDER POWER |
---|
-27.52 |
Last 100 transactions |
Buy: 215 643 | Sell: 404 694 |
Volumen Korrelation
Abiomed, Inc. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Abiomed, Inc. Korrelation - Währung/Rohstoff
Abiomed, Inc. Finanzdaten
Annual | 2022 |
Umsatz: | $1.03B |
Bruttogewinn: | $843.60M (81.76 %) |
EPS: | $3.00 |
FY | 2022 |
Umsatz: | $1.03B |
Bruttogewinn: | $843.60M (81.76 %) |
EPS: | $3.00 |
FY | 2021 |
Umsatz: | $847.52M |
Bruttogewinn: | $685.62M (80.90 %) |
EPS: | $5.00 |
FY | 2020 |
Umsatz: | $840.88M |
Bruttogewinn: | $689.58M (82.01 %) |
EPS: | $4.49 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Abiomed, Inc.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.